The Health Canada clearance for Biotricity's Biotres device is a significant regulatory milestone that allows the company to market its product in Canada. This approval is likely to have a positive impact on the company's stock price in the short term due to the potential for increased market presence and revenue opportunities in a new geographical market. The importance of this regulatory approval is high as it directly affects the company's ability to sell its product and expand its operations.